<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35173147</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.</ArticleTitle><Pagination><StartPage>156</StartPage><MedlinePgn>156</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">156</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-022-04602-5</ELocationID><Abstract><AbstractText>Mitochondrial dysfunction is becoming one of the main pathology factors involved in the etiology of neurological disorders. Recently, mutations of the coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2) and 10 (CHCHD10) which encode two homologous proteins that belong to the mitochondrial CHCH domain protein family, are linked to Parkinson's disease and amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD), respectively. However, the physiological and pathological roles of these twin proteins have not been well elaborated. Here, we show that, in physiological conditions, CHCHD2 and CHCHD10 interact with OMA1 and suppress its enzyme activity, which not only restrains the initiation of the mitochondrial integrated response stress (mtISR), but also suppresses the processing of OPA1 for mitochondrial fusion. Further, during mitochondria stress-induced by carbonyl cyanide m-chlorophenylhydrazone (CCCP) treatment, CHCHD2 and CHCHD10 translocate to the cytosol and interacte with eIF2a, which attenuates mtISR overactivation by suppressing eIF2a phosphorylation and its downstream response. As such, knockdown of CHCHD2 and CHCHD10 triggers mitochondrial ISR, and such cellular response is enhanced by CCCP treatment. Therefore, our findings demonstrate the first "mtISR suppressor" localized in mitochondria for regulating stress responses in mammalian cells, which has a profound pathological impact on the CHCH2/CHCH10-linked neurodegenerative disorder.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Sixth Affiliated Hospital of Jinan University, Jinan University, Dongguan, Guangdong, 523560, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, 510632, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jiaqiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Sixth Affiliated Hospital of Jinan University, Jinan University, Dongguan, Guangdong, 523560, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Che</LastName><ForeName>Yaping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Sixth Affiliated Hospital of Jinan University, Jinan University, Dongguan, Guangdong, 523560, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Sixth Affiliated Hospital of Jinan University, Jinan University, Dongguan, Guangdong, 523560, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhenhuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Sixth Affiliated Hospital of Jinan University, Jinan University, Dongguan, Guangdong, 523560, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Center for Brain Science and Brain-Inspired Technology, Shanghai, 201210, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>He</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-1805-4659</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China. hehe2013@whu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Qinghua</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0003-0468-9266</Identifier><AffiliationInfo><Affiliation>The Sixth Affiliated Hospital of Jinan University, Jinan University, Dongguan, Guangdong, 523560, China. gene@email.jnu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, 510632, China. gene@email.jnu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>555-60-2</RegistryNumber><NameOfSubstance UI="D002258">Carbonyl Cyanide m-Chlorophenyl Hydrazone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002258" MajorTopicYN="N">Carbonyl Cyanide m-Chlorophenyl Hydrazone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063154" MajorTopicYN="N">Mitochondrial Dynamics</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35173147</ArticleId><ArticleId IdType="pmc">PMC8850591</ArticleId><ArticleId IdType="doi">10.1038/s41419-022-04602-5</ArticleId><ArticleId IdType="pii">10.1038/s41419-022-04602-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mishra P, Chan DC. Mitochondrial dynamics and inheritance during cell division, development and disease. Nat Rev Mol Cell Biol. 2014;15:634&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4250044</ArticleId><ArticleId IdType="pubmed">25237825</ArticleId></ArticleIdList></Reference><Reference><Citation>Loson OC, Song Z, Chen H, Chan DC. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 2013;24:659&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3583668</ArticleId><ArticleId IdType="pubmed">23283981</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Ghochani M, McCaffery JM, Frey TG, Chan DC. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell. 2009;20:3525&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719570</ArticleId><ArticleId IdType="pubmed">19477917</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Chen H, Fiket M, Alexander C, Chan DC. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol. 2007;178:749&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2064540</ArticleId><ArticleId IdType="pubmed">17709429</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, Shu L, Huang X, Yu J, Li L, Gong L, et al. OPA1 and MICOS Regulate mitochondrial crista dynamics and formation. Cell Death Dis. 2020;11:940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603527</ArticleId><ArticleId IdType="pubmed">33130824</ArticleId></ArticleIdList></Reference><Reference><Citation>Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126:177&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">16839885</ArticleId></ArticleIdList></Reference><Reference><Citation>Malpass K. Neurodegenerative disease: defective mitochondrial dynamics in the hot seat-a therapeutic target common to many neurological disorders? Nat Rev Neurol. 2013;9:417.</Citation><ArticleIdList><ArticleId IdType="pubmed">23877644</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Chan DC. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet. 2009;18:R169&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758711</ArticleId><ArticleId IdType="pubmed">19808793</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Chan DC. Mitochondrial dynamics in mammals. Curr Top Dev Biol. 2004;59:119&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">14975249</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Aviles G, Liu Y, Tian R, Unger BA, Lin YT, et al. Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway. Nature. 2020;579:427&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147832</ArticleId><ArticleId IdType="pubmed">32132707</ArticleId></ArticleIdList></Reference><Reference><Citation>Fessler E, Eckl EM, Schmitt S, Mancilla IA, Meyer-Bender MF, Hanf M, et al. A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol. Nature. 2020;579:433&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116715</ArticleId><ArticleId IdType="pubmed">32132706</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiros PM, Prado MA, Zamboni N, D&#x2019;Amico D, Williams RW, Finley D, et al. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J Cell Biol. 2017;216:2027&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496626</ArticleId><ArticleId IdType="pubmed">28566324</ArticleId></ArticleIdList></Reference><Reference><Citation>Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson&#x2019;s disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015;14:274&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">25662902</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller K, Andersen PM, Hubers A, Marroquin N, Volk AE, Danzer KM, et al. Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease. Brain. 2014;137:e309.</Citation><ArticleIdList><ArticleId IdType="pubmed">25113787</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaussenot A, Le Ber I, Ait-El-Mkadem S, Camuzat A, de Septenville A, Bannwarth S, et al. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. Neurobiol Aging. 2014;35:2884 e2881&#x2013;2884 e2884.</Citation><ArticleIdList><ArticleId IdType="pubmed">25155093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurzwelly D, Kruger S, Biskup S, Heneka MT. A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation. Brain: a J Neurol. 2015;138:e376.</Citation><ArticleIdList><ArticleId IdType="pubmed">25681414</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone F, Nguyen HP, Van Mossevelde S, Moisse M, Sieben A, Santens P, et al. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients. Neurobiol Aging. 2017;51:177 e179&#x2013;177 e116.</Citation><ArticleIdList><ArticleId IdType="pubmed">28069311</ArticleId></ArticleIdList></Reference><Reference><Citation>Auranen M, Ylikallio E, Shcherbii M, Paetau A, Kiuru-Enari S, Toppila JP, et al. CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease. Neurol Genet. 2015;1:e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4821082</ArticleId><ArticleId IdType="pubmed">27066538</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasanen P, Myllykangas L, Poyhonen M, Kiuru-Enari S, Tienari PJ, Laaksovirta H, et al. Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val. Acta Neurol Scand. 2016;133:361&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26224640</ArticleId></ArticleIdList></Reference><Reference><Citation>Penttila S, Jokela M, Saukkonen AM, Toivanen J, Palmio J, Lahdesmaki J, et al. CHCHD10 mutations and motor neuron disease: the distribution in Finnish patients. J Neurol Neurosurg Psychiatry. 2017;88:272&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27810918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Fecto F, Ajroud K, Lalani I, Calvo SE, Mootha VK, et al. Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy. Neurogenetics. 2015;16:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4796476</ArticleId><ArticleId IdType="pubmed">25193783</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Meng HR, Shiba-Fukushima K, Hattori N. Twin CHCH Proteins, CHCHD2, and CHCHD10: key molecules of Parkinson&#x2019;s disease, amyotrophic lateral sclerosis, and frontotemporal dementia. Int J Mol Sci. 2019;20:908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6412816</ArticleId><ArticleId IdType="pubmed">30791515</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein SR, Valsecchi F, Kawamata H, Bourens M, Zeng R, Zuberi A, et al. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Hum Mol Genet. 2018;27:160&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886281</ArticleId><ArticleId IdType="pubmed">29112723</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Wu BP, Nguyen D, Liu YT, Marani M, Hench J, et al. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Hum Mol Genet. 2019;28:349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322067</ArticleId><ArticleId IdType="pubmed">30285108</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub IR, Janer A, Weraarpachai W, Zinman L, Robertson J, Rogaeva E, et al. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS. Hum Mol Genet. 2018;27:178&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886208</ArticleId><ArticleId IdType="pubmed">29121267</ArticleId></ArticleIdList></Reference><Reference><Citation>Aras S, Pak O, Sommer N, Finley R, Jr., Huttemann M, Weissmann N, et al. Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2. Nucleic Acids Res. 2013;41:2255&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575822</ArticleId><ArticleId IdType="pubmed">23303788</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman LI, Purandare N, Arshad R, Gladyck S, Somayajulu M, Huttemann M, et al. MNRR1, a biorganellar regulator of mitochondria. Oxid Med Cell Longev. 2017;2017:6739236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480048</ArticleId><ArticleId IdType="pubmed">28685009</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Clegg HV, Leslie PL, Di J, Tollini LA, He Y, et al. CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation. Cell Death Differ. 2015;22:1035&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4423185</ArticleId><ArticleId IdType="pubmed">25476776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, Noda S, Torii S, Amo T, Ikeda A, Funayama M, et al. Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice. Human molecular genetics. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33631794</ArticleId></ArticleIdList></Reference><Reference><Citation>Purandare N, Somayajulu M, Huttemann M, Grossman LI, Aras S. The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): partners in mitochondrial and nuclear function and dysfunction. J Biol Chem. 2018;293:6517&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5925800</ArticleId><ArticleId IdType="pubmed">29540477</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Bannwarth S, Lespinasse F, Ortega-Vila B, Fragaki K, Itoh K, et al. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases. Neurobiol Dis. 2018;119:159&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015038</ArticleId><ArticleId IdType="pubmed">30092269</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Plutino M, Bannwarth S, Villa E, Cisneros-Barroso E, Roy M, et al. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol Med. 2016;8:58&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718158</ArticleId><ArticleId IdType="pubmed">26666268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Ma D, Sun AX, Tran HD, Ma DL, Singh BK, et al. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction. Hum Mol Genet. 2019;28:1100&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6423417</ArticleId><ArticleId IdType="pubmed">30496485</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YT, Huang X, Nguyen D, Shammas MK, Wu BP, Dombi E, et al. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations. Hum Mol Genet. 2020;29:1547&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268789</ArticleId><ArticleId IdType="pubmed">32338760</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CJ, Bredvik K, Burstein SR, Davis C, Meadows SM, Dash J, et al. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response. Acta Neuropathologica. 2019;138:103&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6571048</ArticleId><ArticleId IdType="pubmed">30877432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Y, Li H, Zhang K, Jian F, Tang J, Song Z. Loss of Yme1L perturbates mitochondrial dynamics. Cell Death Dis. 2013;4:e896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920928</ArticleId><ArticleId IdType="pubmed">24176854</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondadi AK, Anand R, Reichert AS. Cristae Membrane Dynamics - A Paradigm Change. Trends Cell Biol. 2020;30:923&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">32978040</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Wu BP, Nguyen D, Liu YT, Marani M, Hench J, et al. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Hum Mol Genet. 2018;27:3881&#x2013;3900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6216204</ArticleId><ArticleId IdType="pubmed">30084972</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D, Liu YT, Huang XP, Nguyen D, Shammas M, Wu B, et al. Loss of CHCHD2 and CHCHD10 Activates Oma1 Peptidase to Disrupt Mitochondrial Cristae Phenocopying Patient Mutations. Ann Neurol. 2020;88:S215&#x2013;S215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268789</ArticleId><ArticleId IdType="pubmed">32338760</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YT, Huang XP, Nguyen D, Shammas MK, Wu BP, Dombi E, et al. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations. Hum Mol Genet. 2020;29:1547&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268789</ArticleId><ArticleId IdType="pubmed">32338760</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang XP, Wu BP, Nguyen D, Liu YT, Marani M, Hench J, et al. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Hum Mol Genet. 2018;27:3881&#x2013;3900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6216204</ArticleId><ArticleId IdType="pubmed">30084972</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol. 2010;30:1303&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2832503</ArticleId><ArticleId IdType="pubmed">20100866</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wan OW, Xie W, Chung KK. p32 regulates mitochondrial morphology and dynamics through parkin. Neuroscience. 2011;199:346&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">22008525</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh S, Phorl S, Naskar R, Oeum K, Seo Y, Kim E, et al. p32/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis. Sci Rep. 2020;10:10618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327069</ArticleId><ArticleId IdType="pubmed">32606429</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Duan XY, Xu LN, Shang WN, Zhao JY, Wang LQ, et al. Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1. Cell Death Differ. 2020;27:2014&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244760</ArticleId><ArticleId IdType="pubmed">31907391</ArticleId></ArticleIdList></Reference><Reference><Citation>Alavi MV. OMA1-An integral membrane protease? Biochim Biophys Acta Proteins Proteom. 2021;1869:140558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7770061</ArticleId><ArticleId IdType="pubmed">33130089</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Zuo M, Zeng L, Cui K, Liu B, Yan C, et al. OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development. EMBO Rep. 2021;22:e50827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7788456</ArticleId><ArticleId IdType="pubmed">33314701</ArticleId></ArticleIdList></Reference><Reference><Citation>Correction for Aras et al., Mitochondrial Nuclear Retrograde Regulator 1 (MNRR1) rescues the cellular phenotype of MELAS by inducing homeostatic mechanisms. Proc Natl Acad Sci USA. 2021;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896324</ArticleId><ArticleId IdType="pubmed">33526597</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian F, Chen D, Chen L, Yan C, Lu B, Zhu Y, et al. Sam50 regulates PINK1-Parkin-Mediated mitophagy by controlling PINK1 Stability and mitochondrial morphology. Cell Rep. 2018;23:2989&#x2013;3005.</Citation><ArticleIdList><ArticleId IdType="pubmed">29874585</ArticleId></ArticleIdList></Reference><Reference><Citation>Baghirova S, Hughes BG, Hendzel MJ, Schulz R. Sequential fractionation and isolation of subcellular proteins from tissue or cultured cells. MethodsX. 2015;2:440&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4678309</ArticleId><ArticleId IdType="pubmed">26740924</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Zhang K, Dong J, Yan C, Hu C, Ji H, et al. Sam50-Mic19-Mic60 axis determines mitochondrial cristae architecture by mediating mitochondrial outer and inner membrane contact. Cell Death Differ. 2020;27:146&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206006</ArticleId><ArticleId IdType="pubmed">31097788</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>